Jump to content

Biotechnology patent applications on 4th September 2025

From WikiPatents
Revision as of 15:17, 6 September 2025 by Wikipatents (talk | contribs) (Technology trend analysis for Biotechnology patent applications on 4th September 2025)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Biotechnology Patent Applications on 4th September 2025

Executive Summary

On 4th September 2025, 123 patent applications related to Biotechnology were published, representing 2.3% of all patent applications for the day. This moderate level of activity shows Biotechnology is gaining significant attention from innovators.

Market Analysis

Leading Organizations

The top organizations driving Biotechnology innovation include:

Template:Newsletter signup box

These 5 organizations account for 10 applications (8.1% of all Biotechnology patents), indicating a diverse and competitive landscape.

Technology Deep Dive

Core Innovation Areas

Patent applications in Biotechnology encompass several key innovation areas:

Technical Classification Analysis

The most active CPC classifications in Biotechnology include:

  • C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 22 applications (17.9%)
  • C12N2750/14143 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 13 applications (10.6%)
  • A61P35/00 (Antineoplastic agents): 11 applications (8.9%)
  • C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 10 applications (8.1%)
  • C12N2310/315 (of the backbone): 10 applications (8.1%)
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 10 applications (8.1%)
  • C12Q1/6806 (Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (): 10 applications (8.1%)
  • C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 9 applications (7.3%)
  • C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay): 8 applications (6.5%)
  • A61K48/005 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 8 applications (6.5%)

Global Innovation Landscape

Innovation in Biotechnology spans multiple countries:

  • US: 255 inventors (50.2%)
  • CN: 57 inventors (11.2%)
  • KR: 56 inventors (11.0%)
  • DE: 23 inventors (4.5%)
  • FR: 22 inventors (4.3%)
  • CA: 10 inventors (2.0%)
  • CH: 10 inventors (2.0%)
  • GB: 9 inventors (1.8%)
  • IL: 9 inventors (1.8%)
  • DK: 9 inventors (1.8%)

The US accounts for 50.2% of inventors in Biotechnology, showing significant but not dominant innovation activity.

Industry Collaborations

Notable collaborations in Biotechnology include:

These collaborations represent 5 joint applications, indicating emerging collaboration trends in Biotechnology.

Leading Inventors

Key inventors driving Biotechnology innovation:

Recent Patent Applications

Representative Biotechnology patent applications from 4th September 2025:

20250275512. Arugula Variety 'CN SROC 2520'

Applicant: Cn Seeds Ltd

Abstract: An arugula cultivar, designated ‘CN SROC 2520’ is disclosed. The invention relates to seeds of ‘CN SROC 2520’, plants and plant parts of ‘CN SROC 2520’, methods of producing an arugula plant by breeding with ‘CN SROC 2520’, arugula plants or plant parts derived from ‘CN SROC 2520’, including ‘CN SROC 2520’-derived seed(s) and plant(s) obtained through breeding or by introducing a transgene or mutation.

20250275540. USE OF PROTOPORPHYRINOGEN OXIDASE

Applicant: Beijing Dabeinong Biotechnology Co Ltd

Abstract: The present invention relates to use of protoporphyrinogen oxidase. A method for controlling weeds comprises applying a herbicide containing an effective dose of PPO inhibitor to a field with at least one transgenic plant. The transgenic plant has a polynucleotide sequence encoding protoporphyrinogen oxidase in a genome thereof, and has reduced plant damage and/or increased plant production compared to other plants that do not have a polynucleotide sequence encoding protoporphyrinogen oxidase. A...

20250275921. COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING LIPID NANOPARTICLES

Applicant: Enhancedbio Inc

Abstract: The present application relates to a composition for preventing or treating cancer, containing lipid nanoparticles. A pharmaceutical composition according to one embodiment has excellent biocompatibility, can deliver gene therapeutic agents and the like with high efficiency, thereby having excellent cancer prevention or treatment effects, and has excellent cancer prevention or treatment effects even if used in combination with anticancer agents and/or radiation therapy.

20250275931. TOPICAL PATCH COMPOSITION FOR TARGETED SIRNA NANOPLEX DELIVERY AND GENE THERAPIES AND METHOD OF MAKING AND USE THEREOF

Applicant: NANYANG TECHNOLOGICAL UNIVERSITY, National Skin Centre (Singapore) Pte Ltd

Abstract: Provided herein is a dissolvable microneedle patch comprising a tip portion, wherein the tip portion comprises a nanoplex formed from a positively charged biopolymer which incorporates a cell targeting moiety and a siRNA. In one embodiment, the positively charged biopolymer is formed from gelatin and tyramine, the cell targeting moiety is gelatin, and the siRNA is siSPARC. Also provided herein is the use of the dissolvable microneedle patch in therapy, specifically in the treatment of a skin con...

20250275999. HIGH PURITY RNA COMPOSITIONS AND METHODS FOR PREPARATION THEREOF

Applicant: ModernaTX Inc

Abstract: The invention relates to improved RNA compositions for use in therapeutic applications. The RNA compositions are particularly suited for use in human therapeutic application (e.g., in RNA therapeutics). The RNA compositions are made by improved processes, in particular, improved in vitro-transcription (IVT) processes. The invention also relates to methods for producing and purifying RNA (e.g, therapeutic RNAs), as well as methods for using the RNA compositions and therapeutic applications thereo...

Market Implications

Innovation Intensity

With 123 applications in a single day, Biotechnology demonstrates very high innovation intensity, suggesting rapid technological advancement and strong commercial interest.

Competitive Landscape

Innovation in Biotechnology involves 132 organizations, indicating a highly competitive and diverse landscape with many players investing in R&D.

Technology Outlook

Emerging themes in Biotechnology patents include: methods, acid, nucleic, with, comprising, suggesting future development in these areas.

The current patent activity level suggests Biotechnology is in a growth phase with increasing market adoption and investment.

Related Technology Areas

Innovation in Biotechnology often intersects with other emerging technologies:

Analysis Tools

Search Resources

See Also

Retrieved from "https://wikipatents.org/index.php?title=Biotechnology_patent_applications_on_4th_September_2025&oldid=671226"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.